mTOR controls ChREBP transcriptional activity and pancreatic β cell survival under diabetic stress

52Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Impaired nutrient sensing and dysregulated glucose homeostasis are common in diabetes. However, how nutrient-sensitive signaling components control glucose homeostasis and β cell survival under diabetic stress is not well understood. Here, we show that mice lacking the core nutrient-sensitive signaling component mammalian target of rapamycin (mTOR) in β cells exhibit reduced β cell mass and smaller islets. mTOR deficiency leads to a severe reduction in β cell survival and increased mitochondrial oxidative stress in chemical-induced diabetes. Mechanistically, we find that mTOR associates with the carbohydrate-response element-binding protein (ChREBP)-Max-like protein complex and inhibits its transcriptional activity, leading to decreased expression of thioredoxin-interacting protein (TXN IP), a potent inducer of β cell death and oxidative stress. Consistent with this, the levels of TXN IP and ChREBP were highly elevated in human diabetic islets and mTOR-deficient mouse islets. Thus, our results suggest that a nutrient-sensitive mTOR-regulated transcriptional network could be a novel target to improve β cell survival and glucose homeostasis in diabetes.

Cite

CITATION STYLE

APA

Chau, G. C., Im, D. U., Kang, T. M., Bae, J. M., Kim, W., Pyo, S., … Um, S. H. (2017). mTOR controls ChREBP transcriptional activity and pancreatic β cell survival under diabetic stress. Journal of Cell Biology, 216(7), 2091–2105. https://doi.org/10.1083/jcb.201701085

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free